Compare NVAX & TIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVAX | TIC |
|---|---|---|
| Founded | 1987 | 1991 |
| Country | United States | United States |
| Employees | N/A | 12760 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 1996 | N/A |
| Metric | NVAX | TIC |
|---|---|---|
| Price | $7.93 | $6.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $11.33 | $11.20 |
| AVG Volume (30 Days) | ★ 4.2M | 1.7M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 309.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,123,479,000.00 | N/A |
| Revenue This Year | N/A | $44.09 |
| Revenue Next Year | N/A | $4.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 64.69 | N/A |
| 52 Week Low | $6.20 | $6.36 |
| 52 Week High | $11.85 | $14.94 |
| Indicator | NVAX | TIC |
|---|---|---|
| Relative Strength Index (RSI) | 32.66 | 23.96 |
| Support Level | $7.78 | $6.36 |
| Resistance Level | $10.10 | $9.01 |
| Average True Range (ATR) | 0.42 | 0.35 |
| MACD | -0.14 | -0.12 |
| Stochastic Oscillator | 3.52 | 3.78 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
TIC Solutions Inc is a provider of tech-enabled Testing, Inspection, Certification and Compliance (TICC), engineering, and geospatial services. It provides mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. The company's services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets. It operates in North America and serve both public- and private-sector clients. Its public-sector clients include federal, state, and municipal agencies, public utilities, and environmental regulators. Its private-sector clients span industrial, infrastructure, construction, and real estate end markets.